ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2020; 4(4): 141-144


Uterine artery embolization for symptomatic fibroid disease in a patient with Stanford type B aortic dissection: a case report

Eleanor Danek, Warren Clements.



Abstract
Download PDF Cited by 0 ArticlesPost

Background: Patients with connective tissue disease are a potentially challenging population to treat via an endovascular approach. Treatments carry a risk of new or further dissection, including at the arteriotomy, and challenges navigating true or false lumen.
Case presentation: The authors present a case of a patient with a recent aortic dissection in the setting of presumed connective tissue disease, with coincidental symptomatic uterine fibroids, successfully treated via uterine artery embolization.
Conclusion: To the author’s knowledge, this case report is the first to describe successful uterine artery embolization in a patient with existing type b dissection. With proper technique and preparation, uterine artery embolization and other endovascular treatments remain a viable treatment option in this patient population.

Key words: Case report, fibroids, embolization, leiomyoma, adenomyosis, dissection







Bibliomed Article Statistics

30
18
25
24
22
20
43
42
27
29
18
7
R
E
A
D
S

17

12

13

8

5

12

16

19

13

15

11

1
D
O
W
N
L
O
A
D
S
070809101112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.